"Obesity is a chronic disease and a lifetime struggle
Small dose, real result, no overwhelm
Some individuals experience mild side effects, such as nausea or fatigue, within the first 24 to 48 hours after an injection
20, 2023 /PRNewswire/ -- Ro , the leading direct-to-patient healthcare company, announced today the launch of the Ro Body Program , a comprehensive weight loss program that provides access to GLP-1 medications, the most effective prescription obesity treatments available
Effective on all skin types for anti-aging, acne scar reduction, stretch marks, improved skin tone, and texture
Comorbidities: Type 2 diabetes: Both are FDA-approved for diabetes (tirzepatide as Mounjaro, semaglutide as Ozempic) Cardiovascular disease: Semaglutide has the cardiovascular outcomes data Sleep apnea: Tirzepatide has shown benefits Injection frequency: Both are once-weekly